Methylation of RBM39 by PRMT6 enhances resistance to Indisulam in non-small cell lung cancer by promoting alternative splicing of proto-oncogenes

Methylation of RBM39 by PRMT6 enhances resistance to Indisulam in non-small cell lung cancer by promoting alternative splicing of proto-oncogenes

Saved in:

Bibliographic Details
Main Authors:	Tongjia Zhang, Shujie Wang, Yue Zhou, Zitao Jiao, Kejia Lu, Xinyi Liu, Hui Li, Wei Jiang, Xiaowei Zhang
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2025-06-01
Series:	PLoS Biology
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12142651/?tool=EBI
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The RBM39 degrader indisulam inhibits acute megakaryoblastic leukemia by altering the alternative splicing of ZMYND8
by: Ying Yang, et al.
Published: (2025-04-01)

The PRMT5-splicing axis is a critical oncogenic vulnerability that regulates detained intron splicing
by: Colin E. Fowler, et al.
Published: (2025-07-01)

RBM47 functions as an anti-oncogene by regulating expression and alternative splicing of cell proliferation and apoptosis associated genes in colorectal cancer cells
by: Guangshi Liu, et al.
Published: (2025-07-01)

Rbm3 deficiency leads to transcriptome-wide splicing alterations
by: Steffen Erkelenz, et al.
Published: (2024-12-01)

Child with RET proto-oncogene codon 634 mutation
by: Dilek İnce, et al.
Published: (2017-10-01)

Corrigendum to “PRMT1 methylates METTL14 to modulate its oncogenic function” [Neoplasia 42 (2023) 100912]
by: Jingchao Wang, et al.
Published: (2025-07-01)

Regulation of rDNA transcription by proto-oncogene PELP1.
by: Vijay K Gonugunta, et al.
Published: (2011-01-01)

GP73-mediated secretion of PKM2 and GP73 promotes angiogenesis and M2-like macrophage polarization in hepatocellular carcinoma
by: Shujie Wang, et al.
Published: (2025-02-01)

Correction: GP73-mediated secretion of PKM2 and GP73 promotes angiogenesis and M2-like macrophage polarization in hepatocellular carcinoma
by: Shujie Wang, et al.
Published: (2025-05-01)

RBM39 shapes innate immunity by controlling the expression of key factors of the interferon response
by: Teng-Feng Li, et al.
Published: (2025-04-01)

Spatial transcriptomics identifies RBM39 as a gene associated with Gleason score progression in prostate cancer
by: Yongjun Quan, et al.
Published: (2024-12-01)

Alternative Splicing in Oncogenic Kinases: From Physiological Functions to Cancer
by: Sabine Druillennec, et al.
Published: (2012-01-01)

ASO targeting RBM3 temperature‐controlled poison exon splicing prevents neurodegeneration in vivo
by: Marco Preußner, et al.
Published: (2023-03-01)

Indisulam synergizes with melphalan to inhibit Multiple Myeloma malignancy via targeting TOP2A.
by: Chengyu Wu, et al.
Published: (2024-01-01)

Germline Variants in Proto-Oncogenes and Tumor Suppressor Genes in Women with Cervical Cancer
by: Ksenia Lenkova, et al.
Published: (2024-10-01)

Oncogenic Alternative Splicing Switches: Role in Cancer Progression and Prospects for Therapy
by: Serena Bonomi, et al.
Published: (2013-01-01)

PRMT1 alleviates isoprenaline-induced myocardial hypertrophy by methylating SRSF1
by: Yan Zi, et al.
Published: (2024-12-01)

Proto‐Oncogene HRAS Transcript Level and Overall Survival in Stages II and III Colorectal Cancer
by: Donghyun Kim, et al.
Published: (2025-08-01)

DEK proto-oncogene is highly expressed in astrocytic tumors and regulates glioblastoma cell proliferation and apoptosis
by: Tianda Feng, et al.
Published: (2017-06-01)

Surgical and clinical strategies in the management of thyroid medullary carcinoma in children with and without ret proto-oncogene mutations
by: Özlem Boybeyi-Türer, et al.
Published: (2016-08-01)

Retraction Note: MALAT1 regulates the transcriptional and translational levels of proto-oncogene RUNX2 in colorectal cancer metastasis
by: Qing Ji, et al.
Published: (2025-03-01)

STAU1 exhibits oncogenic characteristics and modulates alternative splicing and gene expression in lung adenocarcinoma cells
by: Ling Zhang, et al.
Published: (2025-05-01)

Drug discovery with an RBM20 dependent titin splice reporter identifies cardenolides as lead structures to improve cardiac filling.
by: Martin Liss, et al.
Published: (2018-01-01)

PRMT1‐mediated arginine methylation promotes YAP activation and hepatocellular carcinoma proliferation
by: Jian Yu, et al.
Published: (2024-12-01)

ETS proto-oncogene 1 modulates PTP1B expression to participate in high glucose-mediated endothelial inflammation
by: Jiang Lili, et al.
Published: (2022-03-01)

The Programmed Cell Death of an Immature ThymocyteCell Line Transgenic for an αβ TCR and the c-mycProto-Oncogene
by: Marianna Murdjeva, et al.
Published: (1995-01-01)

A novel peptide 66CTG stabilizes Myc proto-oncogene protein to promote triple-negative breast cancer growth
by: Huichun Liang, et al.
Published: (2025-07-01)

PRMT1 promotes immune escape in hepatocellular carcinoma by regulating arginine methylation modification of MYC protein
by: Han Zhou, et al.
Published: (2025-12-01)

Mutational Landscape of <i>KIT</i> Proto-Oncogene Coding Sequence in 62 Canine Cutaneous and Subcutaneous Mast Cell Tumors
by: Ludovica Montanucci, et al.
Published: (2024-11-01)

PRMT1 inhibitor MS023 suppresses RNA splicing to sensitize small cell lung cancer to DNA damaging agents
by: Mansi K. Aparnathi, et al.
Published: (2025-08-01)

PRMT5-Mediated Arginine Methylation of ACSL4 Attenuates Its Stability and Suppresses Ferroptosis in Renal Cancer
by: Meng Zhang, et al.
Published: (2025-01-01)

MYB Proto-Oncogene Like 2 identified as a biomarker for uterine corpus endometrial carcinoma: evidence from bioinformatics and clinical validation
by: Jiaoyun Lu, et al.
Published: (2025-05-01)

The methyltransferases PRMT4/CARM1 and PRMT5 control differentially myogenesis in zebrafish.
by: Julie Batut, et al.
Published: (2011-01-01)

PRMT5-mediated methylation of METTL3 promotes cisplatin resistance in ovarian cancer by facilitating DNA repair mechanisms
by: Qiaoxi Xia, et al.
Published: (2025-04-01)

Tumor-intrinsic PRMT5 upregulates FGL1 via methylating TCF12 to inhibit CD8+ T-cell-mediated antitumor immunity in liver cancer
by: Jiao Sun, et al.
Published: (2025-01-01)

Genetic ancestry concordant RNA splicing in prostate cancer involves oncogenic genes and associates with recurrence
by: Muthana Al Abo, et al.
Published: (2025-01-01)

Psip1/Ledgf p52 binds methylated histone H3K36 and splicing factors and contributes to the regulation of alternative splicing.
by: Madapura M Pradeepa, et al.
Published: (2012-01-01)

PRMT5 Promotes Pancreatic Cancer Tumorigenesis via Positive PRMT5/C‐Myc Feedback Loop
by: Fan Yang, et al.
Published: (2025-06-01)

Coupling of alternative splicing and alternative polyadenylation
by: Zhang Xueying, et al.
Published: (2024-12-01)

PRMT1-catalyzed NUSAP1 methylation enhances Notch2 signaling and 5-FU resistance in gastric cancer
by: Suting Jiang, et al.
Published: (2025-05-01)